America's Biggest Banks Passed Their Stress Tests. Now They're Showering Investors With Cash.

The Fed’s 2026 stress test was passed by all 32 largest U.S. banks, even under a severe recession scenario with $708B+ in modeled loan losses, which immediately translated into higher shareholder payouts. JPMorgan raised its quarterly dividend 10% to $1.65 and authorized a new $50B buyback (effective July 1), Goldman lifted its dividend 11% to $5.00/share, Morgan Stanley increased its dividend 15% to $1.15/share and reauthorized up to $20B of buybacks, while Wells Fargo raised its dividend 11% to $0.50/share and continues buybacks, with buffers largely unchanged after the SCB floor (e.g., JPM/ WFC at 2.5%). Overall, the wave of dividends/buybacks signals regulatory comfort, though valuation comparisons suggest the payout size alone doesn’t guarantee better stock returns—Wells stands out on the highest dividend yield (~2.4%) and lower P/E (~13).

Analysis

The market is likely to over-credit the headline payouts and underweight the fact that this is mostly a signal of regulatory slack, not an earnings step-function. For JPM and WFC, the binding constraint is no longer capital adequacy; the more important variable is whether buybacks can overcome slower net interest income as rates normalize. That makes the next 1-3 months a relative-value tape, not a broad sector rerate: names with the cleanest capital return per dollar of valuation should outperform, while richer multiples need more than authorization announcements to justify premium pricing.

The second-order effect is that this reinforces a widening split inside large-cap banks: balance-sheet-heavy lenders with stable capital generation can keep shrinking share count, while trading-heavy franchises have to keep proving that their payout capacity survives a softer market environment. GS and MS look strongest as a confidence statement, but their higher stress buffers mean the market is implicitly paying for a more volatile earnings stream; if equities and advisory activity cool, those buybacks become less relevant to intrinsic value than they appear today. WFC is the cleanest valuation/vs-yield expression if the goal is to own capital return without paying up for multiple premium.

Contrarian view: the consensus is treating the stress test as a green light for the whole group, but the test is backward-looking and model-driven. The real falsifier is not the authorization size, but next quarter’s CET1 drift, loan-loss build, and SCB trajectory into next year’s cycle. If capital ratios stop improving or the Fed tightens the capital framework again, these announcements become mostly cosmetic and the stock-specific upside compresses quickly.

Key Decisions for Investors

• Long WFC / short GS for 1-3 months: express valuation + yield versus higher-multiple, higher-SCB cyclicality; thesis fails if Goldman revenue momentum reaccelerates or WFC buybacks disappoint.
• Add JPM on pullbacks, not chase strength: the buyback is the most mechanically accretive among the group, but the stock already embeds quality; use as a defensive bank long with a 6-12 month horizon and watch CET1 drift as the key falsifier.
• Avoid paying up for MS purely on the dividend raise: the 15% increase is a signal, but the stock needs market-activity upside to earn its premium; prefer to own it only if equity/IB volumes inflect in the next 1-2 quarters.
• Relative-value watch item: if bank multiples expand on the stress-test news without upward EPS revisions, fade the move via XLF strength against the richest large-cap banks; the catalyst would be a softer NII outlook or next-year SCB pressure.